Inside Precision Medicine Marketplace Translational Research Agilent SureSelect Human All Exon V8

Agilent
Agilent SureSelect Human All Exon V8

The SureSelect Human All Exon V8 provides comprehensive and the most up-to-date coverage of protein coding regions from RefSeq, CCDS, and GENCODE. It also covers the TERT promoter and hard-to-capture exons that are omitted by other exomes on the market. Powered by machine learning-based probe design and a new production process, SureSelect Human All Exon V8 spans a 35.1 Mb target region of the human genome with an efficient end-to-end design size of only 41.6 Mb. The panel delivers excellent enrichment performance, as well as efficient, cost-effective exome sequencing. In addition, the panel is manufactured in large scale to provide consistent results for many years.




Agilent

5301 Stevens Creek Blvd
Santa Clara, CA 95051
800-227-9770
https://www.agilent.com





Features & Specs

  • Powered by machine-learning based probe design and manufactured using a new production process to produce probes that will last years to provide consistent results
  • Excellent coverage uniformity and efficient probe design enable variant calling with high confidence while reducing sequencing costs
  • Targets the most up-to-date protein coding regions from RefSeq, GENCODE, and CCDS, including hard-to-capture exons that are omitted from other exomes, and the TERT promoter
  • Natively supported by the Bravo Automated Liquid Handling Platform for high-throughput sample preparation, and the Magnis NGS Prep System for complete, walkaway automation
  • Streamlined and optimized variant analysis, interpretation, and reporting via Alissa Reporter and Alissa Interpret, providing an efficient, scalable, and highly secure cloud-based solution

Features & Specs

  • Powered by machine-learning based probe design and manufactured using a new production process to produce probes that will last years to provide consistent results
  • Excellent coverage uniformity and efficient probe design enable variant calling with high confidence while reducing sequencing costs
  • Targets the most up-to-date protein coding regions from RefSeq, GENCODE, and CCDS, including hard-to-capture exons that are omitted from other exomes, and the TERT promoter
  • Natively supported by the Bravo Automated Liquid Handling Platform for high-throughput sample preparation, and the Magnis NGS Prep System for complete, walkaway automation
  • Streamlined and optimized variant analysis, interpretation, and reporting via Alissa Reporter and Alissa Interpret, providing an efficient, scalable, and highly secure cloud-based solution